Risk of major adverse cardiovascular events for concomitant use of clopidogrel and proton pump inhibitors in patients inheriting CYP2C19 loss-of-function alleles: meta-analysis
Mohitosh Biswas, Shawonur Rahaman, Tapash Kumar Biswas, Baharudin Ibrahim
Topics & Concepts
ClopidogrelCYP2C19MedicineMeta-analysisStroke (engine)Internal medicinePharmacologyAdverse effectAntiplatelet drugCoronary artery diseaseProton-pump inhibitorCardiologyMyocardial infarctionEngineeringCytochrome P450Mechanical engineeringMetabolismAntiplatelet Therapy and Cardiovascular DiseasesDiabetes Treatment and ManagementSynthesis of β-Lactam Compounds